Skip to main content
. Author manuscript; available in PMC: 2019 Aug 28.
Published in final edited form as: Expert Opin Drug Discov. 2018 Feb 26;13(5):445–457. doi: 10.1080/17460441.2018.1443074

Table 3:

PD-L1 Expression in Squamous Cell Carcinomas Versus Adenocarcinomas

SCCA AdenoCa P-value
N (%) N (%)
Tumor Cells PD-L1+ >5% 83 (54) 7 (14) <0.001
PD-L1 neg 71 (46) 42 (86)
Diffuse PD-L1 71 (87) 4 (80)
Marginal PD-L1 11 (13) 1 (20) 0.533
PDL1+ TAM Yes 79 (53) 6 (12) <0.001
No 70 (47) 43 (88)
Stromal
PD-L1+ cells
High numbers 122 (78) 31 (65) 0.057
Low numbers 34 (22) 17 (35)

Adapted from Hereen AM, et al. Modern Pathol 2016; 29: 753–63.